Chemoproteomics for Plasmodium Parasite Drug Target Discovery

Area of Science:

• Parasitology
• Medicinal Chemistry
• Biochemistry

Background:

• Drug resistance in Plasmodium parasites poses a significant threat to global malaria control efforts.
• Recent high-throughput screening has yielded novel antimalarial drugs, but their mechanisms of action remain largely unknown.
• Identifying drug targets is crucial for optimizing antimalarial drug leads and prioritizing preclinical development.

Purpose of the Study:

• To review current chemoproteomic strategies for antimalarial drug target discovery.
• To highlight the application of these methods in understanding Plasmodium drug interactions.
• To discuss the potential of chemoproteomics for identifying targets in challenging Plasmodium life stages.

Main Methods:

• Discussion of affinity-based protein profiling.
• Explanation of activity-based protein profiling.
• Overview of energetics-based techniques: thermal proteome profiling and stability of proteins from rates of oxidation (SOP).

Main Results:

• Chemoproteomic approaches enable direct assessment of drug-protein interactions.
• Successful application in the Plasmodium blood stage demonstrates the utility of these methods.
• These techniques can link antimalarial inhibitors to their specific molecular targets.

Conclusions:

• Chemoproteomics offers powerful tools for elucidating antimalarial drug mechanisms of action.
• These methods are vital for overcoming the challenge of unknown targets in drug discovery.
• Future applications may extend to elusive Plasmodium life stages and other intracellular pathogens.